NCT03315455 Efficacy, Safety, and Pharmacokinetic Study of Prophylactic Emicizumab Versus No Prophylaxis in Hemophilia A Participants Status COMPLETED Phase PHASE3
NCT03312530 A Study of Cobimetinib Administered as Single Agent and in Combination With Venetoclax, With or Without Atezolizumab, in Participants With Relapsed and Refractory Multiple Myeloma Status COMPLETED Phase PHASE1/PHASE2
NCT03301883 A Study of Tocilizumab in Chinese Participants With Systemic Juvenile Idiopathic Arthritis (sJIA) Status COMPLETED Phase PHASE4
NCT03297606 Canadian Profiling and Targeted Agent Utilization Trial (CAPTUR) Status RECRUITING Phase PHASE2
NCT03293992 A Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7058584 Following 7 Days of Instillation of Eye Drops in Patients With Primary Open Angle Glaucoma or Ocular Hypertension Status COMPLETED Phase PHASE1
NCT03292172 A Study to Evaluate the Safety, Pharmacokinetics and Clinical Activity of RO6870810 and Atezolizumab (PD-L1 Antibody) in Participants With Advanced Ovarian Cancer or Triple Negative Breast Cancer Status TERMINATED Phase PHASE1
NCT03291457 A Study to Evaluate the Use of Glucocorticoids in Combination With Tocilizumab in Daily Clinical Practice Status COMPLETED Phase N/A
NCT03289182 An Observational Study of MabThera Subcutaneous (SC) Safety in Participants With Non-Hodgkin's Lymphoma (NHL) or Chronic Lymphocytic Leukemia (CLL) Status COMPLETED Phase N/A
NCT03287245 A Study to Evaluate the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Idasanutlin Monotherapy in Participants With Hydroxyurea-Resistant/Intolerant Polycythemia Vera Status TERMINATED Phase PHASE2
NCT03285763 A Study of Atezolizumab (Tecentriq) to Investigate Long-term Safety and Efficacy in Previously-treated Participants With Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) Status COMPLETED Phase PHASE4
NCT03281954 Clinical Trial of Neoadjuvant Chemotherapy With Atezolizumab or Placebo in Patients With Triple-Negative Breast Cancer Followed After Surgery by Atezolizumab or Placebo Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT03281369 A Study of Multiple Immunotherapy-Based Treatment Combinations in Patients With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Cancer (G/GEJ) or Esophageal Cancer (Morpheus-Gastric and Esophageal Cancer) Status COMPLETED Phase PHASE1/PHASE2
NCT03280563 A Study of Multiple Immunotherapy-Based Treatment Combinations in Hormone Receptor (HR)-Positive Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Breast Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT03280550 A Clinical Trial of Omalizumab in Participants With Chronic Rhinosinusitis With Nasal Polyps Status COMPLETED Phase PHASE3
NCT03280537 A Clinical Trial of Omalizumab in Participants With Chronic Rhinosinusitus With Nasal Polyps Status COMPLETED Phase PHASE3
NCT03274492 A Study Comparing the Efficacy and Safety of Polatuzumab Vedotin With Rituximab-Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab-Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Diffuse Large B-Cell Lymphoma Status COMPLETED Phase PHASE3
NCT03273153 A Study of Cobimetinib Plus Atezolizumab Versus Pembrolizumab in Participants With Previously Untreated Advanced BRAFv600 Wild-Type Melanoma Status TERMINATED Phase PHASE3
NCT03271554 Treatment Registry of Alectinib in Anaplastic Lymphoma Kinase (ALK)-Positive, Locally Advanced or Metastatic Non-Small Cell Lung Cancer in Korea Status COMPLETED Phase N/A
NCT03271541 A Study of Bitopertin (RO4917838) in Adults With Non-Transfusion-Dependent (NTD) Beta-Thalassemia Status COMPLETED Phase PHASE2
NCT03264066 A Study to Investigate the Efficacy and Safety of Cobimetinib Plus Atezolizumab in Participants With Solid Tumors Status COMPLETED Phase PHASE2